ALPS Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.46M | Buy |
31,458
+13,894
| +79% | +$1.12M | 0.01% | 456 |
|
|
2026
Q1 | $1.52M | Sell |
17,564
-1,267
| -7% | -$121K | 0.01% | 457 |
|
|
2025
Q4 | $1.81M | Sell |
18,831
-84
| -0.4% | -$8.16K | 0.01% | 410 |
|
|
2025
Q3 | $1.8M | Sell |
18,915
-8,377
| -31% | -$770K | 0.01% | 403 |
|
|
2025
Q2 | $2.38M | Sell |
27,292
-135
| -0.5% | -$11.4K | 0.01% | 340 |
|
|
2025
Q1 | $2.46M | Buy |
27,427
+290
| +1% | +$25.9K | 0.01% | 317 |
|
|
2024
Q4 | $2.17M | Sell |
27,137
-90
| -0.3% | -$7.79K | 0.01% | 337 |
|
|
2024
Q3 | $2.45M | Sell |
27,227
-22,385
| -45% | -$1.88M | 0.02% | 324 |
|
|
2024
Q2 | $3.9M | Hold |
49,612
| – | – | 0.03% | 255 |
|
|
2024
Q1 | $4.32M | Buy |
49,612
+648
| +1% | +$55.3K | 0.03% | 248 |
|
|
2023
Q4 | $4.03M | Sell |
48,964
-281,860
| -85% | -$21.5M | 0.03% | 244 |
|
|
2023
Q3 | $25.9M | Buy |
330,824
+22,727
| +7% | +$1.9M | 0.22% | 53 |
|
|
2023
Q2 | $27.1M | Sell |
308,097
-41,599
| -12% | -$3.58M | 0.24% | 59 |
|
|
2023
Q1 | $28.2M | Sell |
349,696
-4,479
| -1% | -$365K | 0.25% | 60 |
|
|
2022
Q4 | $27.5M | Buy |
354,175
+318,789
| +901% | +$25.8M | 0.25% | 55 |
|
|
2022
Q3 | $2.86M | Sell |
35,386
-7,539
| -18% | -$678K | 0.03% | 233 |
|
|
2022
Q2 | $3.85M | Buy |
+42,925
| New | +$4.35M | 0.04% | 205 |
|
|
2021
Q4 | – | Sell |
-3,458
| Closed | -$433K | – | 940 |
|
|
2021
Q3 | $433K | Buy |
3,458
+385
| +13% | +$49.8K | ﹤0.01% | 516 |
|
|
2021
Q2 | $381K | Buy |
+3,073
| New | +$386K | ﹤0.01% | 608 |
|
|
2020
Q2 | – | Sell |
-21,760
| Closed | -$1.96M | – | 812 |
|
|
2020
Q1 | $1.96M | Buy |
21,760
+729
| +3% | +$77.6K | 0.03% | 213 |
|
|
2019
Q4 | $2.39M | Sell |
21,031
-1,010
| -5% | -$111K | 0.02% | 212 |
|
|
2019
Q3 | $2.39M | Buy |
22,041
+14,952
| +211% | +$1.56M | 0.02% | 198 |
|
|
2019
Q2 | $690K | Buy |
+7,089
| New | +$647K | 0.01% | 459 |
|
|
2019
Q1 | – | Sell |
-34,096
| Closed | -$3.1M | – | 963 |
|
|
2018
Q4 | $3.1M | Buy |
+34,096
| New | +$3.19M | 0.02% | 190 |
|
|
2018
Q3 | – | Sell |
-14,104
| Closed | -$1.21M | – | 1034 |
|
|
2018
Q2 | $1.21M | Buy |
14,104
+1,218
| +9% | +$102K | 0.01% | 298 |
|
|
2018
Q1 | $1.03M | Buy |
+12,886
| New | +$1.06M | 0.01% | 307 |
|
Other funds holding MDT
ALPS Advisors's MDT Position: Q2 2026 in Review
ALPS Advisors increased its Medtronic (MDT) stake by 79% in Q2 2026, buying an estimated $1.12M and bringing the position to 31,458 shares worth $2.46M. The position accounts for 0.01% of the portfolio, ranked #456.
ALPS Advisors first reported a position in MDT in Q1 2018 and has held it in 26 quarters since. The position peaked at $28.2M in Q1 2023. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- ALPS Advisors held 31,458 shares of Medtronic worth $2.46M as of Q2 2026.
- ALPS Advisors bought 13,894 Medtronic shares in Q2 2026, an estimated $1.12M.
- Medtronic made up 0.01% of ALPS Advisors's portfolio in Q2 2026, its #456 holding.
- ALPS Advisors first reported a position in Medtronic in Q1 2018 and has held it in 26 quarters since.
- ALPS Advisors's Medtronic position peaked at $28.2M in Q1 2023.
- 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.